Jamie Balaji Rao
Niner Pharmaceuticals LLC is a pharmaceutical, healthcare, and wellness company based in Business Bay, Dubai, United Arab Emirates. The company specializes in peptides, exosomes, biologicals, wellness products, and specialty therapeutics aimed at delivering innovation-driven and affordable healthcare solutions globally.
Niner Pharmaceuticals LLC operates with a mission to bridge the gap between cutting-edge science and global healthcare accessibility through high-quality pharmaceutical and regenerative medicine solutions.
History
Niner Pharmaceuticals LLC was established under the leadership of Jamie Balaji Rao, an entrepreneur and healthcare strategist with extensive experience in pharmaceuticals, international business, and healthcare innovation.
The company operates across multiple jurisdictions including the UAE, USA, EU, GCC, India, and Hong Kong, focusing on global healthcare distribution and pharmaceutical partnerships.
JB Medcare successfully acquired UAE-based Niner Pharmaceuticals, strengthening the company’s presence in the pharmaceutical and wellness industry.
Vision and Mission
Vision
To make innovative medicine affordable for every patient on earth and establish Niner Pharmaceuticals as a global benchmark for accessible innovation in peptides, biologicals, and specialty therapeutics by 2030.
Mission
Niner Pharmaceuticals LLC develops, manufactures, and supplies innovation-driven medicines and wellness solutions with a focus on affordability, accessibility, and uncompromised quality.
The company aims to deliver:
- Verified-purity peptides
- Biologicals
- Exosomes
- Specialty pharmaceuticals
- Regenerative healthcare solutions
Core Principles
The organization operates on the philosophy:
“Innovation without exclusivity. Quality without compromise. Access without borders.”
Its strategic pillars include:
- Affordable innovation
- Global accessibility
- Uncompromised pharmaceutical quality
- UAE-origin trust architecture
- Transparent and sustainable healthcare supply chains
- Mission-driven commercial practices
Services and Products
Niner Pharmaceuticals LLC specializes in:
- Peptide-based therapies
- Exosome-driven treatments
- Stem-cell-related healthcare solutions
- Biologicals
- Specialty therapeutics
- Wellness products
- Pharmaceutical distribution
- AI-driven healthcare collaborations
The company supplies pharmaceutical and wellness products to:
- Institutional buyers
- Governments
- Hospitals
- Research organizations
- Healthcare partners
Operations
Niner Pharmaceuticals LLC operates with a global distribution network anchored in Dubai and supported by strategic hubs in:
- Dubai
- New Jersey
- Hong Kong
- Bangalore
The company focuses on:
- International pharmaceutical distribution
- Research collaborations
- Healthcare innovation
- Regenerative medicine
- Strategic healthcare partnerships
Leadership
Jamie Balaji Rao
Jamie Balaji Rao is the Managing Director and CEO of Niner Pharmaceuticals LLC. He is an entrepreneur, healthcare strategist, startup investor, and business leader known for building partnerships in peptides, exosomes, stem-cell therapies, and AI-driven healthcare solutions.
Born on 9 May 1989, Jamie Balaji Rao was born in Odisha, India. He completed his schooling in Odisha, was raised in Bangalore, and later settled in Dubai, United Arab Emirates.
He holds:
- MBA in International Business and Trade
- PhD in International Business, Bilateral Trade and Relationships from Harvard University, USA
Jamie Balaji Rao has more than 18 years of experience in pharmaceuticals, healthcare strategy, international business, and wellness industries.
Professional Experience
Niner Pharmaceuticals LLC
- Managing Director & CEO (2022 – Present)
JB CROP
- CEO and Business Analyst (2008 – Present)
JB MEDCARE
- Company Owner (2021 – 2022)
Jamie Balaji Rao has also been involved in startup investments, healthcare collaborations, and global pharmaceutical partnerships.
Philosophy
Niner Pharmaceuticals LLC emphasizes affordable innovation and believes that advanced healthcare solutions should be accessible globally without compromising quality standards.
The organization’s positioning statement highlights its commitment toward:
- Innovation-driven healthcare
- Affordable medicine
- Global healthcare accessibility
- Regulatory-compliant pharmaceutical excellence
Taglines
- “Innovation. Affordable. Everywhere.”
- “Better Medicine. Within Reach.”
- “Affordable Innovation. Global Access.”
- “The Future of Medicine — Made Accessible.”
- “Where Innovation Meets Access.”